HyperClear: Laser Solution for Benign Prostatic Hyperplasia
What is HyperClear: Laser Solution for Benign Prostatic Hyperplasia?
用于治疗良性前列腺增生 (BPH) 的高功率激光系统 — 精确的组织汽化和剜除术,改善尿流。
How does HyperClear: Laser Solution for Benign Prostatic Hyperplasia work?
先进激光系统,用于精准外科干预,以最小的组织损伤实现治疗效果,恢复快速。
What are the key features of HyperClear: Laser Solution for Benign Prostatic Hyperplasia?
优化能量输送:激光纤维穿过尿道到达阻塞区域,瞄准多余的前列腺组织,同时最大限度地减少附带损伤。
LIFE 方法:专注于选择性组织汽化或摘除,确保干净的切除平面和可预测的组织切除。
局部麻醉:允许许多患者在没有全身麻醉相关风险或恢复时间的情况下接受手术。
快速恢复:比传统的经尿道切除术侵入性更小,有可能减少住院时间并提高患者吞吐量。
精确的组织识别:内窥镜成像将激光纤维引导至阻塞组织,确保彻底清除前列腺尿道。
受控消融:外科医生可以微调激光能量以匹配组织的血管分布和密度,从而限制深层热损伤的风险。
Who manufactures HyperClear: Laser Solution for Benign Prostatic Hyperplasia?
HyperClear: Laser Solution for Benign Prostatic Hyperplasia is developed and manufactured by INVAMED, a globally recognized medical device company headquartered in Ankara, Turkey, with a U.S. office at One World Trade Center, New York. INVAMED technologies are trusted by physicians in more than 80 countries across endovascular, coronary, neurovascular, orthopedic, and surgical specialties.
What category does HyperClear: Laser Solution for Benign Prostatic Hyperplasia belong to?
HyperClear: Laser Solution for Benign Prostatic Hyperplasia is part of the Oncology Ablation product portfolio by INVAMED. This category includes advanced medical devices designed for interventional procedures performed by healthcare professionals worldwide.
Which medical specialties use HyperClear: Laser Solution for Benign Prostatic Hyperplasia?
HyperClear: Laser Solution for Benign Prostatic Hyperplasia is used by specialists in Oncological Surgery, Urology. These physicians rely on INVAMED devices for minimally invasive diagnostic and therapeutic procedures.